Department of Inorganic and Analytical Chemistry, University of Szeged, Dóm tér 7, H-6720 Szeged, Hungary; University of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.
Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, H-1117 Budapest, Hungary.
J Inorg Biochem. 2018 Apr;181:74-85. doi: 10.1016/j.jinorgbio.2017.12.017. Epub 2018 Jan 6.
Five Ru(II)(η-toluene) complexes formed with 2-picolinic acid and its various derivatives have been synthesized and characterized. X-ray structures of four complexes are also reported. Complex formation processes of [Ru(II)(η-toluene)(HO)] organometallic cation with the metal-free ligands were studied in aqueous solution in the presence of chloride ions by the combined use of H NMR spectroscopy, UV-visible spectrophotometry and pH-potentiometry. Solution stability, chloride ion affinity and lipophilicity of the complexes were characterized together with in vitro cytotoxic and antiproliferative activity in cancer cell lines being sensitive and resistant to classic chemotherapy and in normal cells as well. Formation of mono complexes such as [Ru(η-toluene)(L)(Z)] (L: completely deprotonated ligand; Z = HO/Cl) with high stability and [Ru(η-toluene)(L)(OH)] was found in solution. The pK values (8.3-8.7) reflect the formation of low amount of mixed hydroxido species at pH 7.4 at 0.2 M KCl ionic strength. The complexes are fairly hydrophilic and show moderate chloride ion affinity and fast chloride-water exchange processes. The studied complexes exhibit no cytotoxic activity in human cancer cells (IC > 100 μM), only complexes formed with 2-picolinic acid (1) and its 3-methyl derivative (2) represented a moderate antiproliferative effect (IC = 84.8 (1), 79.2 μM (2)) on a multidrug resistant colon adenocarcinoma cell line revealing considerable multidrug resistant selectivity. Complexes 1 and 2 bind to human serum albumin covalently and relatively slowly with moderate strength at multiple binding sites without ligand cleavage.
已经合成并表征了五个 Ru(II)(η- 甲苯) 配合物,它们是由 2- 吡啶甲酸及其各种衍生物形成的。还报道了四个配合物的 X 射线结构。通过结合使用 H NMR 光谱、紫外可见分光光度法和 pH 电位法,在含有氯离子的水溶液中研究了 [Ru(II)(η- 甲苯)(HO)] 有机金属阳离子与无金属配体的配合物形成过程。还研究了配合物的溶液稳定性、氯离子亲和力和疏水性,以及它们在对经典化疗敏感和耐药的癌细胞系以及正常细胞中的体外细胞毒性和抗增殖活性。在溶液中发现形成了具有高稳定性的单核配合物,如 [Ru(η- 甲苯)(L)(Z)](L:完全去质子化的配体;Z=HO/Cl)和[Ru(η- 甲苯)(L)(OH)]。pK 值(8.3-8.7)反映了在 0.2 M KCl 离子强度下 pH 值为 7.4 时形成的低量混合羟化物。这些配合物具有相当的亲水性,表现出适度的氯离子亲和力和快速的氯离子-水交换过程。所研究的配合物在人癌细胞中没有细胞毒性(IC>100 μM),只有与 2- 吡啶甲酸(1)及其 3- 甲基衍生物(2)形成的配合物对多药耐药结肠腺癌细胞系表现出适度的抗增殖作用(IC=84.8(1),79.2 μM(2)),显示出相当大的多药耐药选择性。配合物 1 和 2与人血清白蛋白共价结合,结合强度适中,结合位点多,配体不易断裂,结合速度较慢。